About: 3,4-Dimethylmethcathinone

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world. 3,4-DMMC has been seized as a designer drug in Australia. In vitro, 3,4-DMMC was shown to be a monoamine transporter substrate that potently inhibits norepinephrine and serotonin reuptake, and to a lesser extent dopamine reuptake.

Property	Value
dbo:abstract	3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world. 3,4-DMMC has been seized as a designer drug in Australia. In vitro, 3,4-DMMC was shown to be a monoamine transporter substrate that potently inhibits norepinephrine and serotonin reuptake, and to a lesser extent dopamine reuptake. (en)
dbo:casNumber	1082110-00-6
dbo:fdaUniiCode	C4EW58DTW5
dbo:pubchem	52988261
dbo:thumbnail	wiki-commons:Special:FilePath/3,4-DMMC.svg?width=300
dbo:wikiPageID	33284471 (xsd:integer)
dbo:wikiPageLength	3766 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1084233313 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Designer_drug dbc:Designer_drugs dbc:Serotonin-norepinephrine-dopamine_releasing_agents dbr:Stimulant dbr:Australia dbr:Serotonin–norepinephrine_reuptake_inhibitor dbc:Cathinones dbr:Mephedrone dbr:Methylone dbr:Serotonin–norepinephrine–dopamine_reuptake_inhibitor dbr:Xylopropamine dbr:Indanylaminopropane dbr:Monoamine_transporter dbr:Substituted_cathinone
dbp:atcPrefix	none (en)
dbp:c	12 (xsd:integer)
dbp:casNumber	1082110 (xsd:integer)
dbp:chemspiderid	25630192 (xsd:integer)
dbp:h	17 (xsd:integer)
dbp:iupacName	-1 (xsd:integer)
dbp:legalDe	Anlage II (en)
dbp:legalUk	Class B (en)
dbp:n	1 (xsd:integer)
dbp:o	1 (xsd:integer)
dbp:pubchem	52988261 (xsd:integer)
dbp:smiles	Cc1ccccc1C (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	IBZRXTVDTGVBIS-UHFFFAOYSA-N (en)
dbp:unii	C4EW58DTW5 (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	453845081 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Nervous-system-drug-stub dbt:Phenethylamines dbt:Reflist dbt:Short_description dbt:Stimulants dbt:Cascite dbt:Chemspidercite dbt:Fdacite dbt:Stdinchicite
dcterms:subject	dbc:Designer_drugs dbc:Serotonin-norepinephrine-dopamine_releasing_agents dbc:Cathinones
gold:hypernym	dbr:Drug
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug
rdfs:comment	3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world. 3,4-DMMC has been seized as a designer drug in Australia. In vitro, 3,4-DMMC was shown to be a monoamine transporter substrate that potently inhibits norepinephrine and serotonin reuptake, and to a lesser extent dopamine reuptake. (en)
rdfs:label	3,4-Dimethylmethcathinone (en)
owl:sameAs	freebase:3,4-Dimethylmethcathinone yago-res:3,4-Dimethylmethcathinone wikidata:3,4-Dimethylmethcathinone dbpedia-sh:3,4-Dimethylmethcathinone dbpedia-sr:3,4-Dimethylmethcathinone https://global.dbpedia.org/id/4JRk2
prov:wasDerivedFrom	wikipedia-en:3,4-Dimethylmethcathinone?oldid=1084233313&ns=0
foaf:depiction	wiki-commons:Special:FilePath/3,4-DMMC.svg
foaf:isPrimaryTopicOf	wikipedia-en:3,4-Dimethylmethcathinone
is dbo:wikiPageRedirects of	dbr:3,4-DMMC
is dbo:wikiPageWikiLink of	dbr:List_of_designer_drugs dbr:C12H17NO dbr:Drugs_controlled_by_the_German_Betäubungsmittelgesetz dbr:Xylopropamine dbr:Substituted_cathinone dbr:3,4-DMMC
is foaf:primaryTopic of	wikipedia-en:3,4-Dimethylmethcathinone

This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License